Papers published from the
Texas Arrhythmia Institute
Pacifico A and Henry PD: Ablation for
Atrial Fibrillation: Are Cures Really Achieved? JACC, 2004;43;1940-1943
Pacifico A and Henry PD: Class I or Class
III Agents for Atrial Fibrillation: Are we Asking the Right Question? PACE,
2003;26:1-8
Pacifico A and Henry PD: Structural Pathways and
Prevention of Heart Failure and Sudden Death. J Cardiovasc Electrophysiol, 2003;14:1-12
Bailin SJ, Niebauer M, Tomassoni G, Leman R, and
the Photon Investigators: Clinical Investigation of a New Dual-Chamber
Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination
Capabilities. J Cardiovasc Electrophysiol, 2003;14:144
Herre JM, Sung RJ, Daubert JP, Greene HL, Hofer BO, Klevan
LR, Kron J, Larsen GC, Marinchak RA, Pacifico A, Page RL, Schwartz KM,
Shih T, Moore R, Hallstrom AP and the AVID Investigators: Changing Practice of
Surgery for the Implantable Cardioverter Defibrillator. (In Press)
Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J,
Wyse DG, Friedman PL, Martins JB, Epstein AE, Engelstein ED, Kim SG, Pacifico
A, Belco KM, Steinberg JS, Lancaster S, Greene HL and the AVID Investigators:
Analysis of Implantable Cardioverter Defibrillator Therapy in the Antiarrhythmics
Versus Implantable Defibrillators (AVID) Trial. JACC (In Press)
Shih H-T, Wyse DG, Rizo-Patron C, Stamato NJ, Daubert JP,
Lancaster S, Renfroe EG, Connors N, Pacifico A, Crevey B, Jennings C,
Whiting, Hallstrom AP and the AVID Investigators: Regional Differences in Utilization
of Implantable Cardioverter/Defibrillators- An Antiarrhythmics Versus Implantable
Defibrillators (AVID) Registry Study. (In Press)
Bailin SJ, Niebauer M, Tomassoni G, Leman R, and
the Photon Investigators: Clinical Investigation of a New Dual-Chamber
Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination
Capabilities. J Cardiovasc Electrophysiol, 2003;14:144.
Renfroe EG, Heywood G, Foreman L, Schron E, Powell J,
Baessler C, Warwick D, Morris M, Hallstrom A for the AVID Coordinators and
Investigators: The end-of-study patient survey: Methods influencing response
rate in the AVID trial. Controlled Clinical Trials, 2002;23:521-533.
Brodsky MA, Mitchell LB, Halperin BD, Raitt MH,
Hallstrom AP and the AVID Investigators: Prognostic value of baseline
electrophysiology studies in patients with sustained ventricular tachyarrhythmias:
The antiarrhythmics versus implantable defibrillators (AVID) trial. Am Heart J,
2002;144:478-484.
Cook JR, Rizo-Patron C, Curtis AB, Gillis AM, Bigger
JT Jr, Kutalek SP, Coromilas J, Hoter BL, Powell J, Hallstrom AP for the AVID
Investigators: Effect of surgical revascularization in patients with coronary
artery disease and ventricular tachycardia or fibrillation in the antiarrhythmics
versus implantable defibrillators (AVID) registry. Am Heart J,
2002;143:821-826.
Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte
A, Sullivan S, Brodsky M, Powell J, Marchant C, Jennings C, Akiyama T and the
AVID Investigators: Cost-effectiveness of the implantable
cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious
ventricular tachyarrhythmias: Results of the antiarrhythmics versus implantable
defibrillators (AVID) economic analysis substudy. Circulation,
2002;105:2049-2057.
Pacifico A: Review of Ellenbogen KA,
Kay GN and Wilkoff BL, eds., Clinical Cardiac Pacing and Defibrillation, 2nd Edition.
Circulation, 2002;105:1273.
Fink P, Arndt GD, Carl JR, Beer R, Raffoul G,
Pacifico A, and Henry P: Millimeter-Wave and Microwave Treatment of
Atherosclerosis. NASA Tech Briefs, 2002;26:42-43.
Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg
JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J and the AVID
Investigators: Quality of Life in the Antiarrhythmics Versus Implantable
Defibrillators Trial. Circulation, 2002;105:589-594.
Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson
MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL for the AVID
Investigators: Life-Threatening Ventricular Arrhythmias Due to Transient or
Correctable Causes: High Risk for Death in Follow-Up. J Am Coll Cardiol,
2001;38:1718-1724.
Wyse DG, Love JC, Yao Q, Carlson MD, Cassidy P, Greene
HL, Martins JB, Ocampo C, Raitt MH, Schron E, Stamato NJ, Olarte A and the AVID
Investigators: Atrial Fibrillation: A Risk Factor for Increased Mortality--An
AVID Registry Analysis. J Interventional Cardiac, Electrophysiology
2001;5:267-273.
Ehlert FA, Cannom DS, Renfroe EG, Green HL,
Ledingham R, Mitchell LB, Anderson JL, Halperin BD, Herre JM, Luceri RM, Marinchak
RA, Steinberg JS and the AVID Investigators: Comparison of dilated
cardiomyopathy and coronary artery disease in patients with life- threatening
ventricular arrhythmias: Differences in presentation and outcome in the AVID
registry. Am Heart J, 2001;142:816-822.
Steinberg JS, Martins J, Sadanandan S, Goldner B,
Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom AP and the AVID
Investigators: Antiarrhythmic drug use in the implantable defibrillator arm
of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Am Heart J,
2001;142:520-529.
Steinberg JS, Beckman K, Greene HL, Marinchak R,
Klein RC, Greer SG, Ehlert F, Foster P, Menchavez E, Raitt M, Wathen MS, Morris M,
Hallstrom AP and the Antiarrhythmics Versus Implantable Defibrillators (AVID)
Investigators: Follow-up of Patients with Unexplained Syncope and Inducible
Ventricular Tachyarrhythmias: Analysis of the AVID Registry and an AVID Substudy. J
Cardiovasc Electrophysiol, 2001;12:996-1001.
Hallstrom AP, Greene HL, Wilkoff BL, Zipes DP, Schron
E, Ledingham RB and the Antiarrhythmics versus Implantable Defibrillators
(AVID) Investigators: Relationship Between Rehospitalization and Future Death
in Patients Treated for Potentially Lethal Arrhythmia. J Cardiovasc Electrophysiol,
2001;12:990-995.
Friedman PA, Dijkman B, Warman EN, Zia A, Mehra R,
Stanton MS, Hammill SC for the Worldwide Jewel SF Investigators: Atrial
Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients. Circulation,
2001;104:1023-1028.
Adler SW II, Wolpert C, Warman EN, Musley SK,
Koehler JL, Euler DE for the Worldwide Jewel SF Investigators: Efficacy
of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular
Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator.
Circulation, 2001; 104:887-892.
Akiyama T, Powell JL, Mitchell LB, Ehlert FA and
Baessler C for the Antiarrhythmics versus Implantable Defibrillators
Investigators: Resumption of Driving after Life-Threatening Ventricular
Tachyarrhythmia. N Eng J Med, 2001;345:391-397.
Hickey K, Curtis AB, Lancaster S, Larsen G, Warwick
D, McAnulty J, Mitchell BL and the AVID Investigators: Baseline factors
predicting early resumption of driving after life-threatening arrhythmias in the
Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Am Heart J,
2001;142:99-104.
Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K,
Haffajee CJ for the Worldwide Jewel AF Investigators: Worldwide
Clinical Experience with a New Dual-Chamber Implantable Cardioverter Defibrillator
System. J Cardiovasc Electrophysiol, 2001;12:521-528.
Exner DV, Sheldon RS, Pinski SL, Kron J, Hallstrom A
and the AVID Investigators: Do baseline characteristics accurately
discriminate between patients likely versus unlikely to benefit from implantable
defibrillator therapy? Am Heart J, 2001;141:99-104.
Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M,
Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q and the
AVID Investigators: Lead- and Device-Related Complications in the
Antiarrhythmics Versus Implantable Defibrillators Trial. Am Heart J,
2001;141:92-98.
Hallstrom AP, McAnulty JH, Wilkoff BL, Follman D,
Raitt MH, Carlson MD, Gillis AM, Shih H-T, Powell JL, Duff H, Halperin BD and
the Antiarrhvthmics Versus Implantable Defibrillator (AVID) Trial
Investigators: Patients at Lower Risk of Arrhythmia Recurrence: A Subgroup in
Whom Implantable Defibrillators May Not Offer Benefit. J Am Coll Cardiol,
2001;37:1093-1099.
Exner DV, Pinski SL, Wyse G, Renfroe EG, Follmann
D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP and the AVID
Investigators: Electrical Storm Presages Nonsudden Death: The Antiarrhythmics
Versus Implantable Defibrillators (AVID) Trial. Circulation,
2001;103:2066-2071.
Raitt MH, Renfroe EG, Epstein AE, McAnulty JH,
Mounsey P, Steinberg JS, Lancaster SE, Jadonath RL, Hallstrom AP for the AVID
Investigators: "Stable" Ventricular Tachycardia Is Not a Benign
Rhythm: Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID)
Registry. Circulation, 2001;103:244-252.
Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuch
K-H, Zipes DP, Greene HL, Boczor S, Domanski M, Follman D, Gent M, Roberts RS on
behalf of the Investigators of the AVID, CASH and CIDS studies:
Meta-analysis of the implantable cardioverter defibrillator secondary prevention
trials. Eur Heart J, 2000;21:2071-2078.
Pacifico A and Henry PD: Ablation to Treat
Atrial Fibrillation: First Choice Therapy? (In Press)
Ellenbogen KA, Edel T, Moore S, Higgins S,
Pacifico A, Wilber D, Wood MA, Rogers R, Dahn A, Zhu A and The Ventak AV II
DR Study Investigators: A Prospective Randomized-Controlled Trial of Ventricular
Fibrillation Detection Time in a DDDR Ventricular Defibrillator. PACE,
2000;23:1268-1272.
Pinski SL, Yao Q, Epstein AE, Lancaster S, Greene HL,
Pacifico A, Cook JR, Jadonath R, Marinchak RA and the AVID
Investigators: Determinants of outcome in patients with sustained ventricular
tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Am Heart J, 2000;193:804-813.
The AVID Investigators: Causes of
Death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. JACC,
1999;34:1552-1559.
Epstein AE, Powell J, Yao Q, Ocampo C, Lancaster S,
Rosenberg Y, Cannom DS, Herre JM, Greene HL, and the AVID
Investigators: In-Hospital Versus Out-of-Hospital Presentation of Life-
Threatening Ventricular Arrhythmias Predicts Survival: Results from the AVID
Registry. JACC, 1999;34:1111-1116.
Exner DV, Reiffel JA, Epstein AE, Ledingham R,
Reiter MJ, Yao Q, Duff HJ, Follmann D, Schron E, Greene HL, Carlson MD, Brodsky MQA,
Akiyama T, Baessler C, Anderson JL and the AVID Investigators:
Beta-Blocker Use and Survival in Patients with Ventricular Fibrillation or
Symptomatic Ventricular Tachycardia: The Antiarrhythmics Versus Implantable
Defibrillators (AVID) Trial. J Am Coll Cardiol, 1999;34:325-333.
Pacifico A, Ferlic LL, Cedillo-Salazar
F, Nasir N Jr, Doyle TK, Henry PD. Shocks as Predictors
of Survival in Patients with Implantable Cardioverter-Defibrillators. JACC,
1999;34:204-210.
Pacifico A, Hohnloser SH, Williams JH,
Tao B, Saksena S, Henry PD, Prystowsky EN for the d,I-Sotalol Implantable
Cardioverter-Defibrillator Study Group: Prevention of Implantable Defibrillator
Shocks by Treatment with Sotalol. NEJM, 1999;340:1855-1862.
Olshansky B, Hahn EA, Hartz VL, Prater SP, Mason JW
and the ESVEM Investigators: Clinical Significance of Syncope in the
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial. Am
Heart J, 1999;137:878-886.
Anderson JL, Hallstrom AP, Epstein AE, Pinski SL,
Rosenberg Y, Nora MO, Chilson D, Cannom DS, Moore R and the AVID
Investigators: Design and Results of the Antiarrhythmic vs Implantable
Defibrillators (AVID) Registry. Circulation, 1999;99:1692-1699.
Shusterman V, Benhur A, Gottipaty V, Weiss R, Brode S,
Schwartzman D, Anderson KP for the ESVEM Investigators: Autonomic
Nervous System Activity and the Spontaneous Initiation of Ventricular Tachycardia. J
Am Coll Cardiol, 1998;32:1891-1899.
Brooks MM, Jenkins LS, Schron EB, Steinberg JS,
Cross JA, Paeth DS for the AVID Investigators: Quality of Life at
Baseline: Is Assessment After Randomization Valid? Med Care,
1998;36:1515-1519.
Natale A, Sra J, Akhtar M, Kusmirek L, Tomassoni G,
Leonelli F, Newby K, Beheiry, Pacifico A: Use of Sublingual
Nitroglycerin During Head-Up Tilt-Table Testing in Patients >60 Years of Age. Am J
Cardiol, 1998;82:1210-1213.
Pacifico A, Johnson JW, Stanton MS,
Steinhaus DM, Gabler R, Church T, Henry PD for the Jewel 7219D Investigators:
Comparison of Results in Two Implantable Defibrillators. Am J Cardiol,
1998;82:875-880.
Nevels RD, Arndt GD, Raffoul GW, Carl JR,
Pacifico A: Microwave Catheter Design. IEEE Trans Biomed Eng,
1998;45:885-890.
Henry PD and Pacifico A: Altering
Molecular Mechanisms to Prevent Sudden Arrhythmic Death. Lancet,
1998;351:1276-1278.
Flaker GG, Tummala R, Wilson J for World Wide
Jewel Investigators: Comparison of Right- and Left-Sided Pectoral
Implantation Parameters with the Jewel Active Can Cardiodefibrillator. PACE,
1998;21:447-451.
Pacifico A and Henry PD: Working Toward an
Efficient Electrophysiology Practice. Cardiac Electrophys Review,
1998;2:91-93.
Henry PD and Pacifico A: Sudden Cardiac
Death: Still More Questions Than Answers. G Ital Cardiol, 1997;27:1319-1324.
The AVID Investigators: A Comparison of
Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated
from Near-Fatal Ventricular Arrhythmias. NEJM, 1997;337:1576-1583.
The Atrial Fibrillation Investigation with
Bidisomide (AFIB) Investigators: Treatment of Atrial Fibrillation and
Paroxysmal Supraventricular Tachycardia with Bidisomide. Circulation,
1997;96:2625-2632.
Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW
and the ESVEM Investigators: Predictors of Arrhythmic Death and Cardiac
Arrest in the ESVEM Trial. Circulation, 1997;96: 1888-1892.
Kim SG, Hallstrom A, Love JC, Rosenberg Y, Powell J,
Roth J, Brodsky M, Moore R, Wilkoff B for the AVID Investigators:
Comparison of Clinical Characteristics and Frequency of Implantable Defibrillator Use
Between Randomized Patients in the Antiarrhythmics Vs. Implantable Defibrillators
(AVID) Trial and Nonrandomized Registry Patients. Am J Cardiol,
1997;80:454-457.
Pacifico A, Cedillo-Salazar FR,
Nasir N Jr, Doyle TK, Henry PD: Conscious Sedation With
Combined Hypnotic Agents for Implantation of Implantable Cardioverter-Defibrillators.
JACC, 1997;30:769-73.
Natale A, Sra J, Geiger MJ, Newby K, Akhtar M,
Pacifico A: Right-Side Implant of the Unipolar Single Lead Defibrillation
System. PACE, 1997;20[Pt.I]:1910-1912.
Domanski MJ, Saksena S, Wyse G, Hallstrom A, Schron
EB, Nanda A, Kutalek S and the AVID Investigators: Clinical and
Socioeconomic Profile of Patients with Malignant Ventricular Arrhythmias in 1993 to
1995. Am J Cardiol, 1997;80:299-301.
Arndt GD, Carl JR, Raffoul GW, Karasack VG, Piper CF,
Pacifico A: Microwave Treatment of Cardiac Arrhythmias. Tech Briefs,
1997;21:80-82.
Nasir N Jr, Cedillo-Salazar FR, Doyle
TK, Henry PD, Pacifico A: Effect of Preexisting Epicardial Patch
Electrodes on Defibrillation Thresholds of Unipolar Defibrillators. Am J Cardiol,
1997;79:1408-1409.
Curtis AB, Hallstrom AP, Klein RC, Nath S, Pinski SL,
Epstein AE, Wyse DG, Cannom DS, Renfroe E and the AVID Investigators:
Influence of Patient Characteristics in the Selection of Patients for Defibrillator
Implantation (The AVID Registry). Am J Cardiol, 1997;79:1185-1189.
Reiffel JA, Hahn E, Hartz V, Reiter MJ for the
ESVEM Investigators: Sotalol for Ventricular Tachyarrhythmias: Beta-Blocking
and Class III Contributions, and Relative Efficacy Versus Class I Drugs After Prior
Drug Failure. Am J Cardiol, 1997;79:1048-1053.
Nasir N Jr, Pacifico A, Doyle TK, Earle
NR, Hardage ML, Henry PD and the Cadence Investigators: Spontaneous
Ventricular Tachycardia Treated by Antitachycardia Pacing. Am J Cardiol,
1997;79:820-822.
Pacifico A: Review of Podrid PJ and
Kowey PK, ed., Handbook of Cardiac Arrhythmia. Circulation, 1997;95:757.
Pacifico A, Wheelan KR, Nasir N
Jr, Wells PJ, Doyle TK, Johnson SA, Henry PD: Long-Term
Follow-Up of Cardioverter-Defibrillator Implanted Under Conscious Sedation in
Prepectoral Subfascial Position. Circulation, 1997;95:946-950.
Reiter MJ, Karagounis LA, Mann DE, Reiffel JA, Hahn
E, Hartz V and the ESVEM Investigators: Reproducibility of Drug
Efficacy Predictions by Holter Monitoring in the Electrophysiographic Monitoring
(ESVEM) Trial. Am J Cardiol, 1997;79:315-322.
Bardy GH, Yee R, Jung W for the Active Can
Investigators: Multicenter Experience With a Pectoral Unipolar Implantable
Cardioverter-Defibrillator. J Am Coll Cardiol, 1996;28:400-410.
Zaim S, Zaim B, Rottman J, Mendoza I, Nasir N
Jr, Pacifico A: Characterization of Spontaneous Recurrent Ventricular
Arrhythmias Detected by Electrogram-Storing Defibrillators in Sudden Cardiac Death
Survivors with No Inducible Ventricular Arrhythmias at Baseline Electrophysiologic
Testing. Amer Heart J, 1996;132:274-279.
Güldal M, Karaoguz R, Pacifico A,
Lawrie GM, Akyol T: Undersensing of the Tiny QRS Complexes That Emerged After the
Isolation of the Right Ventricle in a Patient with Ventricular Tachycardia. PACE,
1996;19:868-871.
Nasir N Jr, Swarna US, Boahene KA, Doyle
TK, Pacifico A: Therapy of Sustained Ventricular Arrhythmias with
Amiodarone: Prediction of Efficacy with Serial Electrophysiologic Studies. J
Cardiovasc Pharmacol Therapeut, 1996;I:123-132.
Leonelli FM, Dunn JK, Young JB, Pacifico
A: Natural History, Determinants, and Clinical Relevance of Conduction
Abnormalities Following Orthotopic Heart Transplantation. Am J Cardiol,
1996;77:47-51.
Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia
EV, Chilson DA, Gomes JA, Woosley RL for the Intravenous Amiodarone Multicenter
Trial Group: Intravenous Amiodarone for Recurrent Sustained Hypotensive
Ventricular Tachyarrhythmias. J Am Coll Cardiol, 1996;27: 67-75.
Natale A, Sra J, Axtell K, Akhtar M, Newby K, Kent V,
Brandon MJ, Kearney MM, Pacifico A: Undetected Ventricular Fibrillation
in Transvenous Implantable Cardioverter Defibrillator: Prospective Comparison of
Different Lead System-Device Combinations. Circulation, 1996;93:91-98.
Scheinman MM, Levine JH, Cannom DS, Friehling TD,
Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR for the Intravenous
Amiodarone Multicenter Investigators Group: Dose-Ranging Study of Intravenous
Amiodarone in Patients with Life-Threatening Ventricular Tachyarrhythmias.
Circulation, 1995;92:3264-3272.
Kowey PR, Levine JH, Herre JM, Pacifico
A, Linsay BD, Plumb VJ, Janosik DL, Kopelman HA, Scheinman MM for the
Intravenous Amiodarone Multicenter Investigators Group: Randomized, Double-Blind
Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients with
Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation.
Circulation, 1995;92:3255-3263.
Tokgozoglu LS, Ashizawa T, Pacifico A,
Armstrong RM, Epstein HF, Zoghbi A: Cardiac Involvement in a Large Kindred with
Myotonic Dystrophy: Quantitative Assessment and Relation to Expansion of CTG Repeats.
JAMA, 1995;274:813-819.
Anderson KP, Walker R, Dustman T, Fuller M, Mori M for
the ESVEM Investigators: Spontaneous Sustained Ventricular Tachycardia
in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
J Am Coll Cardiol, 1995;26:489-96.
Reiter MJ, Mann DE, Reiffel JE, Hahn E, Hartz V and
the ESVEM Investigators: Significance and Incidence of Concordance of
Drug Efficacy Predictions by Holter Monitoring and Electrophysiological Study in the
ESVEM Trial. Circulation, 1995;91:1988-1995.
Wood MA, Stambler BS, Damiano RJ, Greenway P,
Ellenbogen KA, and The Guardian ATP 4210 Multicenter Investigators
Group: Lessons Learned From Data Logging in a Multicenter Clinical Trial
Using a Late-Generation Implantable Cardioverter-Defibrillator. J Am Coll Cardiol,
1994:24:1692-1699.
Omoigui NA, Marcus FI, Mason JW, Hahn EA, Hartz VL,
Hlatky MA for the ESVEM Investigators: Cost of Initial Therapy in the
Electrophysiologic Study Versus ECG Monitoring Trial (ESVEM). Circulation,
1995;91:1070-1076.
The AVID Investigators: Antiarrhythmics
Versus Implantable Defibrillators (AVID)-- Rationale, Design, and Methods. Amer J
Cardiol, 1995;75:470-475.
Lehmann MH, Thomas A, Nabih M, Steinman RT, Fromm BS,
Shah M, Norsted SW and Participating Investigators: Sudden Death in
Recipients of First-Generation Implantable Cardioverter-Defibrillators: Analysis of
Terminal Events. J Interven Cardiol, 1994;7:487-50.
Pieper CF, Pacifico A: Improved Spatial
Resolution for Cardiac Mapping Using Current Source Density Electrode Arrays. PACE,
1995;18:34-44.
Nasir N Jr, Taylor A, Doyle TK and
Pacifico A: Evaluation of Intravenous Lidocaine for the Termination of
Sustained Monomorphic Ventricular Tachycardia in Patients with Coronary Artery
Disease With or Without Healed Myocardial Infarction. Amer J Card,
1994:74:1183-1186.
Reiter MJ, Fain ES, Senelly KM, Robertson AD and
the Cadence Investigators: Predictors of Device Activation for Ventricular
Arrhythmias and Survival in Patients with Implantable Pacemakers/Defibrillators.
PACE, 1994;17:1487-1498.
Langston MA, Pieper CF, Pacifico A:
Spectral Analysis of Activation Time Sequences. PACE, 1994;17:1288-1299.
Nasir N Jr, Doyle TK, Wheeler SH,
Pacifico A: Usefulness of Holter Monitoring in Predicting Efficacy of
Amiodarone Therapy for Sustained Ventricular Tachycardia Associated with Coronary
Artery Disease. Amer J Cardiol, 1994;73:554-558.
Leonelli FM, Pacifico A, Young JB:
Frequency and Significance of Conduction Defects Early After Orthotopic Heart
Transplantation. Amer J Cardiol, 1994;73:175-179.
Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka
ML, Ellenbogen KA, Guardian ATP 4210 Multicenter Investigators:
Sensing/Pacing Lead Complications With a Newer Generation Implantable
Cardioverter-Defibrillator: Worldwide Experience from the Guardian ATP 4210 Clinical
Trial. JACC, 1994;23:123-132.
Sager PT, Nademanee K, Antimisiaris M, Pacifico
A, Pruitt C, Godfrey R, Singh BN: Antiarrhythmic Effects of Selective
Prolongation of Refractoriness: Electrophysiologic Actions of Sematilide HCL in
Humans. Circulation, 1993;88:1072-1082.
Mason JW, the ESVEM Investigators: A
Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular
Tachyarrhythmias. NEJM, 1993;329:452-459.
Mason JW, the ESVEM Investigators: A
Comparison of Electrophysiologic Testing with Holter Monitoring to Predict
Antiarrhythmic-Drug Efficacy for Ventricular Tachyarrhythmias. NEJM,
1993;329:445-451.
Pieper CF, Pacifico A: The Epicardial
Field Potential in Dog: Implications for Recording Site Density During Epicardial
Mapping. PACE, 1993;16:1263-1274.
Pieper CF, Blue R, Pacifico A:
Simultaneously Collected Monopolar and Discrete Bipolar Electrograms: Comparison of
Activation Time Detection Algorithms. PACE, 1993;16:426-433.
The ESVEM Investigators: Determinants of
Predicted Efficacy of Antiarrhythmic Drugs in the Electrophysiologic Study Versus
Electrocardiographic Monitoring Trial. Circulation, 1993;87:323-329.
Pieper CF, Pacifico A: Observations on
the Epicardial Activation of the Normal Human Heart. PACE, 1992;15:2295-2307.
Saksena S, Poczobutt-Johanos M, Castle L, Fogoros R,
Alpert B, Kron J, Pacifico A, Griffin J, Ruskin J, Kehoe RF, Yee R,
Dorian P, Kerr CR, Luceri R, Poliseno M: Long-Term Multicenter Experience With A
Second-Generation Implantable Pacemaker-Defibrillator in Patients With Malignant
Ventricular Tachyarrhythmias. J Am Coll Cardiol, 1992;19:490-499.
Pieper CF, Blue R, Pacifico A:
Influence of Time of Sampling Onset on Parameters Used for Activation Time
Determination in Computerized Intraoperative Mapping. PACE, 1991;
14:2187-2192.
Pieper CF, Blue R, Pacifico A:
Activation Time Detection Algorithms Used in Computerized Intraoperative Cardiac
Mapping: A Comparison with Manually Determined Activation Times. J Cardiovasc
Electrophysiol, 1991;2:388-397.
O'Neill PG, Faitelson L, Taylor A, Puleo P,
Roberts R, Pacifico A: Time Course of Creatinine Kinase Release
Following Termination of Sustained Ventricular Dysrhythmias. Am Heart J,
1991;122(3):709-714.
Pieper CF, Blue R, Pacifico A:
Activation Time Detection Algorithms Used in Computerized Intraoperative Cardiac
Mapping: A Comparison with Manually Determined Activation Times. J Cardiovasc
Electrophysiol, 1991;2:388-397.
O'Neill PG, Faitelson L, Taylor A, Puleo P,
Roberts R, Pacifico A: Time Course of Creatinine Kinase Release
Following Termination of Sustained Ventricular Dysrhythmias. Am Heart J,
1991;122(3):709-714.
Pieper CF, Parsons D, Lawrie GM, Lacy J, Roberts R,
Pacifico A: Design and Implementation of New Computerized System for
Intraoperative Cardiac Mapping: Experience During Surgery. J Appl Physiol,
1991;71:1529-1539.
O'Neill PG, Rokey R, Greenberg S, Pacifico
A: Endocardial Tuberculoma Following Antituberculous Therapy. CHEST,
1991;100:1467-1469.
Kotliar C, Smart FW, Sekala ME, Pacifico
A, Pratt CM, Noon GP, DeBakey ME, Young JB: Relationship of Heterotopic
Transplantation to Native Heart Ventricular Arrhythmias. Ann Thorac Surg,
1991;51:987-91.
Freedman FA, Steinnerg JS, the ESVEM
Investigators: Selective Prolongation of Late Potentials by Sodium-Channel
Blocking Antiarrhythmic Drugs: Relation to Slowing of Ventricular Tachycardia. J Am
Coll Cardiol, 1991;17(5):1017-1025.
Lawrie GM, Pacifico A: Surgery for
Ventricular Tachycardia. J Cardiovasc Electrophysiol, 1991;2:65.
O'Neill PG, Lawrie GM, Kaushik R, Harville LF,
Pacifico A: Late Results of the Left Subcostal Approach for Automatic
Implantable Cardioverter Defibrillator Implantation. Am J Cardiol,
1991;67:387.
O'Neill PG, Boahene KA, Lawrie GM, Howell LF,
Pacifico A: The Effect of Patch Polarity on Defibrillation Thresholds. J
Am Coll Cardiol, 1991;17:707.
Pieper CF, Lawrie GM, Roberts R, Pacifico
A: Bandwidth Induced Errors in Parameters Used for Automated Activation Time
Determination During Computerized Intraoperative Cardiac Mapping: Theoretical Limits.
PACE, 1991;14:214.
Lawrie GM, Pacifico A, Kaushik R, Nahas
C, Earle N: Factors Predictive of Results of Direct Ablative Surgery for
Drug-Refractory Ventricular Tachycardia: Analysis of 80 Patients. J Thorac Cardiovasc
Surg, 1991;101:44.
Pieper C, Lawrie GM, Parsons D, Lacy J, Roberts R,
Pacifico A: Experience with Kapton Based Bipolar Electrode Arrays Used
During Intraoperative Computerized Mapping. J Cardiovasc Electrophysiol,
1990;1:496.
Adenosine for PSVT Study Group:
Adenosine for Paroxysmal Supraventricular Tachycardia Dose-Ranging and Comparison
with Verapamil. Ann of Int Med, 1990;113:104.
O'Neill PG, Menendez T, Hust R, Howell J, Espada R,
Pacifico A: Prolonged Ventricular Fibrillation-Salvage Using A New
Percutaneous Cardiopulmonary Support System. Am J Cardiol, 1989;64:545.
Lawrie GM, Pacifico A, Kaushik R:
Transannular Cryoablation of Ventricular Tachycardia. J Thor Cardiovasc Surg,
1989;98:1030.
Lawrie GM, Pacifico A: The Role of
Surgery in the Treatment of Tachyarrhythmias. Int J Cardiol, 1989;25:151.
The ESVEM Investigators: The ESVEM
Trial: Electrophysiology Study Versus Electrocardiographic Monitoring for Selection
of Antiarrhythmic Therapy of Ventricular Tachyarrhythmias. Circulation,
1989;79:1354.
Lawrie GM, Pacifico A, Kaushik R: Results
of Direct Surgical Ablation of Ventricular Tachycardia Not Due to Ischemic Heart
Disease. Ann Surg, 1989;290:713.
Lawrie GM, Kaushik R, Pacifico A: Right
Mini-Thoracotomy: An Adjunct to Left Subcostal AICD Implantation. Ann Thorac Surg,
1989;47:780.
Pacifico A: Non-Pharmacological Treatment
of Cardiac Arrhythmias: Use of Pacemakers, Theoretical Consideration, Technical
Aspects, and Indication. Problems in Critical Care, 1988;2:402-420.
Pratt CM, Francis M, Eaton T, Pacifico A:
Ambulatory ECG Recordings. Current Problems in Cardiology, 1988;8:521.
Seals AA, Lawrie GM, Magro S, Lin HT, Pacifico
A, Roberts R, Wyndham CRC: Surgical Treatment of Atrial Focal Tachycardia in
Adults. J Am Coll Cardiol, 1988;11:1111-7.
Ugolini V, Pacifico A, Smitherman TC,
Mackowiack PA: Pneumococcal Endocarditis Update. Am Heart J,
1986;112(4):813-19.
Van Den Berg E, Pacifico A, Lange RA,
Wheelan KR, Winniford MD, Hillis LD: Measurement of Cardiac Output Without Right
Heart Catheterization: Reliability, Advantages, and Limitations of A Left-Sided
Indicator Dilution Technique. Cathet Cardiovasc Diagn, 1986;12(3):205-08.
Goodman JM, Maher JF, Silver PA, Pacifico
A, Sanders D: The Membrane Proteins of the Methanol-lnduced Peroxisome of
Candida Boidinii. J Biol Chem, 1986;261:464-3468.
Pacifico A, Capra JD: T Cell Hybrids
with Arsonate Specificity. I. Initial Characterization of Antigen-Specific T Cell
Products That Bear A Cross-Reactive Idiotype and Determinants Encoded by the Murine
Major Histocompatibility Complex. J Exp Med, 1980;152:1289-1301.
Pacifico A, Serra P: Attualita' in
Tema Di Cancro Del Polmone. II Policlinico-Sezione Pratica, 1978;85:1-6.
Pacifico A, Serra P: Su Alcuni Aspetti
Patogenetici Dell'Endocardite Infettiva. II Policlinico-Sezione Pratica,
1977;84:222-226.
|